Related Experiment Videos
Binding of catecholamines to human serum albumin
The Journal of Pharmacology and Experimental Therapeutics
|August 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Correction to: Inhibition of cathepsin B by caspase-3 inhibitors blocks programmed cell death in Arabidopsis.
Cell death and differentiation·2018
Inhibition of cathepsin B by caspase-3 inhibitors blocks programmed cell death in Arabidopsis.
Cell death and differentiation·2016
Mechanical load induced by glass microspheres releases angiogenic factors from neonatal rat ventricular myocytes cultures and causes arrhythmias.
Journal of cellular and molecular medicine·2008
Characterization of three PDI-like genes in Physcomitrella patens and construction of knock-out mutants.
Molecular genetics and genomics : MGG·2002
Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults.
The Journal of pharmacology and experimental therapeutics·2026
Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges.
The Journal of pharmacology and experimental therapeutics·2026
PF5190457 reduces fentanyl intake and seeking with a low risk pharmacological profile in male rats.
The Journal of pharmacology and experimental therapeutics·2026
Cardiac homing peptide-decorated epigallocatechin gallate-loaded poly(lactic-co-glycolic acid) nanoparticles alleviate acute myocardial infarction.
The Journal of pharmacology and experimental therapeutics·2026
M1 muscarinic receptor modulation drives sex-specific alterations of Alzheimer's pathophysiology in APPswe/PSEN1ΔE9 mice.
The Journal of pharmacology and experimental therapeutics·2026
Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.
The Journal of pharmacology and experimental therapeutics·2026